Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ZLTQ's Cash to Debt is ranked higher than
87% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 4.48 vs. ZLTQ: No Debt )
ZLTQ' s 10-Year Cash to Debt Range
Min: 6.45   Max: No Debt
Current: No Debt

Equity to Asset 0.68
ZLTQ's Equity to Asset is ranked higher than
74% of the 367 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. ZLTQ: 0.68 )
ZLTQ' s 10-Year Equity to Asset Range
Min: -5.35   Max: 0.89
Current: 0.68

-5.35
0.89
Interest Coverage No Debt
ZLTQ's Interest Coverage is ranked higher than
75% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: 117.58 vs. ZLTQ: No Debt )
ZLTQ' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 5
Z-Score: 11.98
M-Score: -2.56
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -17.33
ZLTQ's Operating margin (%) is ranked higher than
54% of the 372 Companies
in the Global Medical Devices industry.

( Industry Median: 6.25 vs. ZLTQ: -17.33 )
ZLTQ' s 10-Year Operating margin (%) Range
Min: -1082.23   Max: -12.76
Current: -17.33

-1082.23
-12.76
Net-margin (%) -17.29
ZLTQ's Net-margin (%) is ranked higher than
55% of the 372 Companies
in the Global Medical Devices industry.

( Industry Median: 4.71 vs. ZLTQ: -17.29 )
ZLTQ' s 10-Year Net-margin (%) Range
Min: -1111.78   Max: -14.09
Current: -17.29

-1111.78
-14.09
ROE (%) -30.85
ZLTQ's ROE (%) is ranked higher than
53% of the 368 Companies
in the Global Medical Devices industry.

( Industry Median: 5.93 vs. ZLTQ: -30.85 )
ZLTQ' s 10-Year ROE (%) Range
Min: -41.53   Max: -10.18
Current: -30.85

-41.53
-10.18
ROA (%) -21.92
ZLTQ's ROA (%) is ranked higher than
54% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 3.43 vs. ZLTQ: -21.92 )
ZLTQ' s 10-Year ROA (%) Range
Min: -254.68   Max: -9.06
Current: -21.92

-254.68
-9.06
ROC (Joel Greenblatt) (%) -896.57
ZLTQ's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 13.35 vs. ZLTQ: -896.57 )
ZLTQ' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1431.25   Max: -330.43
Current: -896.57

-1431.25
-330.43
» ZLTQ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

ZLTQ Guru Trades in Q2 2013

Chuck Royce 765,000 sh (unchged)
» More
Q3 2013

ZLTQ Guru Trades in Q3 2013

Chuck Royce 553,200 sh (-27.69%)
» More
Q4 2013

ZLTQ Guru Trades in Q4 2013

Jim Simons 364,357 sh (New)
RS Investment Management 978,900 sh (New)
Chuck Royce 410,200 sh (-25.85%)
» More
Q1 2014

ZLTQ Guru Trades in Q1 2014

Steven Cohen 481,900 sh (New)
RS Investment Management 1,165,400 sh (+19.05%)
Chuck Royce Sold Out
Jim Simons 67,400 sh (-81.5%)
» More
» Details

Insider Trades

Latest Guru Trades with ZLTQ

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 13.50
ZLTQ's P/B is ranked higher than
50% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 3.46 vs. ZLTQ: 13.50 )
ZLTQ' s 10-Year P/B Range
Min: 1.79   Max: 14.5
Current: 13.5

1.79
14.5
P/S 6.00
ZLTQ's P/S is ranked higher than
62% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 3.30 vs. ZLTQ: 6.00 )
ZLTQ' s 10-Year P/S Range
Min: 0.17   Max: 7.17
Current: 6

0.17
7.17
EV-to-EBIT -28.05
ZLTQ's EV-to-EBIT is ranked higher than
63% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 44.56 vs. ZLTQ: -28.05 )
ZLTQ' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -28.05

Current Ratio 2.48
ZLTQ's Current Ratio is ranked higher than
66% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. ZLTQ: 2.48 )
ZLTQ' s 10-Year Current Ratio Range
Min: 1.09   Max: 8.23
Current: 2.48

1.09
8.23
Quick Ratio 1.89
ZLTQ's Quick Ratio is ranked higher than
66% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 2.16 vs. ZLTQ: 1.89 )
ZLTQ' s 10-Year Quick Ratio Range
Min: 0.78   Max: 7.85
Current: 1.89

0.78
7.85

Valuation & Return

vs
industry
vs
history
Price/Net Cash 112.30
ZLTQ's Price/Net Cash is ranked higher than
81% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZLTQ: 112.30 )
ZLTQ' s 10-Year Price/Net Cash Range
Min: 3.49   Max: 103.21
Current: 112.3

3.49
103.21
Price/Net Current Asset Value 33.30
ZLTQ's Price/Net Current Asset Value is ranked higher than
78% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZLTQ: 33.30 )
ZLTQ' s 10-Year Price/Net Current Asset Value Range
Min: 3.12   Max: 30.64
Current: 33.3

3.12
30.64
Price/Tangible Book 16.20
ZLTQ's Price/Tangible Book is ranked higher than
56% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 5.99 vs. ZLTQ: 16.20 )
ZLTQ' s 10-Year Price/Tangible Book Range
Min: 2.32   Max: 14.86
Current: 16.2

2.32
14.86
Price/Median PS Value 2.80
ZLTQ's Price/Median PS Value is ranked higher than
54% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. ZLTQ: 2.80 )
ZLTQ' s 10-Year Price/Median PS Value Range
Min: 0.1   Max: 2.68
Current: 2.8

0.1
2.68

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
ZELTIQ Aesthetics Inc is a medical technology company. It develops and commercializes medical products such as 'CoolSculpting System' which is a non-invasive product for the selective reduction of body fat.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide